DMT Facts
Psychedelic;
Description
DMT (N,N-dimethyltryptamine) — the spirit molecule, dimitri — is a naturally-occurring psychedelic of the tryptamine class. It activates serotonin receptors, disrupting the brain's normal sensory filtering and producing the visual and perceptual intensity characteristic of classical psychedelics.[1]
Subjective effects include geometric visual patterns, complete replacement of ordinary reality, entity encounters, ego dissolution, and profound time alteration. The experience is often described as "more real than real" — a total immersion beginning within seconds, with a resemblance to near-death experiences unique among classical psychedelics.[2]
DMT produces no physical dependence, and no human fatality has been attributed to it alone.[3] The main danger arises with ayahuasca: combining the brew's monoamine oxidase-blocking compounds with antidepressants or other serotonin-raising drugs can cause life-threatening overheating and muscle rigidity.[4][5]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 3 – 5 hoursAfter-effects 1 – 4 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 2 hours
- Carries over to
- LSD;
psilocybin; mescaline; 5-MeO-DMT
Effectslikely at a common dose
- Perception
- Color enhancement;
Visual drifting; Symmetrical texture repetition; Spatial disorientation; Environmental patterning; Geometry; Color alteration; Ganzfeld effect; Holotropic state; Visual morphing; +24 possible, including Vestibular distortion, Visual haze / noise - Body
- Pupil dilation;
Spontaneous body sensations; Body high; Vibrations / buzzing; +25 possible, including Dizziness, Motor control impairment, Abnormal heartbeat - Thinking
- Conceptual thinking;
Novelty enhancement; Thought acceleration; Thought connectivity; +27 possible, including Memory suppression, Cognitive impairment, Confusion - Feeling
- none likely · 9 possible, including Emotional lability, Anxiety, Dysphoria
- Self
- Derealization;
+7 possible, including Depersonalization, Communication suppression, Social disconnection - Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 4 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Rickli A, Moning OD, Hoener MC, Liechti ME (2016) Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens — European Neuropsychopharmacology doi:10.1016/j.euroneuro.2016.05.001
- [2]^Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C (2022) Phenomenology and content of the inhaled N,N-dimethyltryptamine (N,N-DMT) experience — Scientific Reports doi:10.1038/s41598-022-11999-8
- [3]^James E, Erritzoe D, Benway T, Joel Z, Timmermann C (2024) Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial — Frontiers in Psychiatry doi:10.3389/fpsyt.2023.1305796
- [4]^Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM, Dinis-Oliveira RJ, Madureira-Carvalho A (2020) Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact — Pharmaceuticals doi:10.3390/ph13110334
- [5]^Ribeiro GSG, Paranhos BAPB, Dörr F, et al. (2026) Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling — Frontiers in Molecular Biosciences doi:10.3389/fmolb.2026.1768402